THTX Relative Valuation
THTX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, THTX is overvalued; if below, it's undervalued.
Historical Valuation
Theratechnologies Inc (THTX) is now in the Fair zone, suggesting that its current forward PS ratio of 1.74 is considered Fairly compared with the five-year average of 7.50. The fair price of Theratechnologies Inc (THTX) is between 1.84 to 5.36 according to relative valuation methord.
Relative Value
Fair Zone
1.84-5.36
Current Price：3.21
Fair
79.64
PE
1Y
3Y
5Y
Trailing
Forward
9.39
EV/EBITDA
Theratechnologies Inc. (THTX) has a current EV/EBITDA of 9.39. The 5-year average EV/EBITDA is 76.68. The thresholds are as follows: Strongly Undervalued below -629.36, Undervalued between -629.36 and -276.34, Fairly Valued between 429.69 and -276.34, Overvalued between 429.69 and 782.71, and Strongly Overvalued above 782.71. The current Forward EV/EBITDA of 9.39 falls within the Historic Trend Line -Fairly Valued range.
29.10
EV/EBIT
Theratechnologies Inc. (THTX) has a current EV/EBIT of 29.10. The 5-year average EV/EBIT is -6.13. The thresholds are as follows: Strongly Undervalued below -30.28, Undervalued between -30.28 and -18.21, Fairly Valued between 5.95 and -18.21, Overvalued between 5.95 and 18.02, and Strongly Overvalued above 18.02. The current Forward EV/EBIT of 29.10 falls within the Strongly Overvalued range.
1.74
PS
Theratechnologies Inc. (THTX) has a current PS of 1.74. The 5-year average PS is 1.88. The thresholds are as follows: Strongly Undervalued below -0.50, Undervalued between -0.50 and 0.69, Fairly Valued between 3.07 and 0.69, Overvalued between 3.07 and 4.27, and Strongly Overvalued above 4.27. The current Forward PS of 1.74 falls within the Historic Trend Line -Fairly Valued range.
34.66
P/OCF
Theratechnologies Inc. (THTX) has a current P/OCF of 34.66. The 5-year average P/OCF is -1.27. The thresholds are as follows: Strongly Undervalued below -40.50, Undervalued between -40.50 and -20.89, Fairly Valued between 18.34 and -20.89, Overvalued between 18.34 and 37.95, and Strongly Overvalued above 37.95. The current Forward P/OCF of 34.66 falls within the Overvalued range.
18.70
P/FCF
Theratechnologies Inc. (THTX) has a current P/FCF of 18.70. The 5-year average P/FCF is 0.26. The thresholds are as follows: Strongly Undervalued below -60.22, Undervalued between -60.22 and -29.98, Fairly Valued between 30.50 and -29.98, Overvalued between 30.50 and 60.73, and Strongly Overvalued above 60.73. The current Forward P/FCF of 18.70 falls within the Historic Trend Line -Fairly Valued range.
Theratechnologies Inc (THTX) has a current Price-to-Book (P/B) ratio of -5.24. Compared to its 3-year average P/B ratio of -4.00 , the current P/B ratio is approximately 30.89% higher. Relative to its 5-year average P/B ratio of 4.56, the current P/B ratio is about -214.72% higher. Theratechnologies Inc (THTX) has a Forward Free Cash Flow (FCF) yield of approximately 4.82%. Compared to its 3-year average FCF yield of -9.20%, the current FCF yield is approximately -152.36% lower. Relative to its 5-year average FCF yield of -7.78% , the current FCF yield is about -161.86% lower.
-5.24
P/B
Median3y
-4.00
Median5y
4.56
4.82
FCF Yield
Median3y
-9.20
Median5y
-7.78
Competitors Valuation Multiple
The average P/S ratio for THTX's competitors is 2.29, providing a benchmark for relative valuation. Theratechnologies Inc Corp (THTX) exhibits a P/S ratio of 1.74, which is -24.26% above the industry average. Given its robust revenue growth of -19.48%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of THTX increased by 150.78% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -1.81 to -16.89.
The secondary factor is the Revenue Growth, contributed -19.48%to the performance.
Overall, the performance of THTX in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch
FAQ
Is Theratechnologies Inc (THTX) currently overvalued or undervalued?
What is Theratechnologies Inc (THTX) fair value?
How does THTX's valuation metrics compare to the industry average?
What is the current P/B ratio for Theratechnologies Inc (THTX) as of Aug 08 2025?
What is the current FCF Yield for Theratechnologies Inc (THTX) as of Aug 08 2025?
What is the current Forward P/E ratio for Theratechnologies Inc (THTX) as of Aug 08 2025?